Kyanos Biotechnologies

Kyanos developed a large-scale plant-based protein production technology, allowing unprecedented yields, cost effectiveness and health safety conditions.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Toulouse, France
  • Currency EUR
  • Founded January 2016
  • Employees 3
  • Incorporation Type C-corp
  • Website kyanos.bio

Company Summary

Kyanos Biotechnologies disrupts protein production with microalgae.
Targeting the global nutraceutical market, our first AFA microalgae products will be distributed through dietary supplement distribution networks, primarily via health professional prescription.
Kyanos' revenue model is to manufacture, refine and sell microorganisms-based active ingredients to both functional food and mainstream food industries.

Team

  • Frédéric Behar
    CMO

    Experienced marketing director at Synphonat, health supplements company amongst French AFA Klamath microalgae pioneers.
    Led the company digital transformation toward integrated omnichannel distribution.

  • Vinh Ly
    Co-Founder & CEO - Project Coordination

    Entrepreneurial and management experience.
    Previously product manager at Airbus for a €160bn aircraft backlog.
    Co-Founder of health supplements, e-commerce ans online consulting companies.

  • Pierre-Alain Hoffmann
    Co-Founder & CSO

    Experience in scale-up and industrialization of microbial industrial porcesses.
    PhD in Biochemistry, more than 60 industrial projects.

  • Fabrice Gascons Viladomat
    Co-Founder & Food-Tech Advisor

    Food entrepreneur for more than 10 years, managing Ederna company and developing high-tech processing technology towards the agro-food industry.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free